Breaking news – Pagina 219 – AMD

Breaking news

Aprile 27, 2022 Alice Lione

Preventing all-cause hospitalizations in type 2 diabetes with sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A narrative review and proposed clinical approach

Schechter M, Fischer M, Mosenzon O
Diabetes Obes Metab. 2022;24(6):969-82

Leggi

Aprile 27, 2022 Alice Lione

Effects of glucagon-like peptide-1 receptor agonists on cardiovascular and renal outcomes: A meta-analysis and meta-regression analysis

Yoshiji S, Minamino H, Tanaka D, et al.
Diabetes Obes Metab. 2022;24(6):1029-37.

Leggi

Aprile 27, 2022 Alice Lione

Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial

Waijer SW, Vart P, Cherney DZI, et al.
Diabetologia. Pub. online 21 Apr 2022.

Leggi

Aprile 27, 2022 Alice Lione

Intensive versus standard treatment of hyperglycemia in acute ischemic stroke patient: a randomized clinical trial subgroups analysis

Torbey MT, Pauls Q, Gentile N, et al.
Stroke. 2022;53(5):1510-5.

Leggi

Aprile 20, 2022 Alice Lione

Impact of SGLT2 Inhibitors on Serum Sodium in Heart Failure With Reduced Ejection Fraction∗

Li S, Levy WC
J Am Coll Cardiol HF. Pub. online 06 Apr 2022

Leggi

Aprile 20, 2022 Alice Lione

Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications Study

Soulimane S, Balkau B, Vogtschmidt YD, et al.
Diabetologia. Pub. online 12 Apr 2022

Leggi

Aprile 20, 2022 Alice Lione

Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes

Li N, Tan H, Xie A, et al.
BMC Endocrine Disorders. 2022;22(1):101

Leggi

Aprile 20, 2022 Alice Lione

CAPTURE: A cross-sectional study on the prevalence of cardiovascular disease in adults with type 2 diabetes in Italy

Russo GT, Corigliano G, Arturi F, et al.
Nutr Metab Cardiovasc Dis. 2022;32(5):1195-1201

Leggi

Aprile 13, 2022 Alice Lione

Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study

Tamborlane WV, Laffel LM, Shehadeh N, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00052-3

Leggi

Aprile 13, 2022 Alice Lione

Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized controlled trials

Neuen BL, Oshima M, Agarwal R, et al.
Circulation. Pub. online 8 Apr 2022

Leggi